Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Waiting for the big Kahuna -- Ignore unavailable to you. Want to Upgrade?

To: bearshark who wrote (22865)	7/31/1998 7:07:00 PM
From: P.T.Burnem	Respond to of 94695

Get ready for a sell off on Monday: NEW YORK, July 31 (Reuters) - Shares in Bergen Brunswig Corp. and AmeriSource Health Corp. fell sharply in after-hours trade Friday after a U.S. District court judge granted a government request to block the merger of the four largest U.S. drug wholesalers into two companies. Judge Stanley Sporkin said in his ruling that he was persuaded by the Federal Trade Commission that McKesson Corp.'s (MCK - news) purchase of AmeriSource Health Corp. (AAS - news) and Cardinal Health Inc.'s (CAH - news) purchase of Bergen Brunswig Corp. (BBC - news) would cause drug prices to rise. Shares in Bergen Brunswig traded at 37-1/16 on the Instinet electronic trading system on light volume, traders said. The stock closed at 52-15/16 on the New York Stock Exchange. AmeriSource traded at 59, also on thin volume in a choppy session, down from a closing price of 76-1/8. McKesson and Cardinal Health were not trading after hours.